Market Overview
The global lipidic cubic phase crystallization service market was valued at USD 293 million in 2024. The market is projected to grow from USD 315 million in 2025 to USD 463 million by 2031, exhibiting a CAGR of 6.9% during the forecast period.
Lipidic Cubic Phase (LCP) crystallization is an advanced technique used for membrane protein structural analysis, particularly for G-protein coupled receptors (GPCRs). This method creates a stable lipid matrix that mimics the native membrane environment, enabling high-resolution crystal growth. The technique involves mixing aqueous and surfactant components to form a threedimensional lattice of lipid bilayers and water channels, which facilitates membrane protein crystallization where traditional methods often fail.
USD 293 million in 2024
2032 USD 463 million by 2031
of 6.9%
Monoolein Segment Dominates the Market Due to its Stability and Versatility in Membrane Protein Studies
1.The market is segmented based on type into: Monoolein Monopalmitolein
Others
Structure Determination for Drug Design
The
https://www.24lifesciences.com
Our Key Players
Cube Biotech
Creative Biostructure
Formulatrix
Anatrace
